The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Open accessAbstract
BACKGROUND: Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory drugs. We therefore investigated potential interactions between aspirin and commonly prescribed arthritis therapies METHODS: We administered the following combinations of drugs for six days: aspirin (81 mg every morning) two hours before ibuprofen (400 mg every morning) and the same medications in the reverse order; aspirin two hours before acetaminophen (1000 mg every morning) and the same medications in the reverse order; aspirin two hours before the cyclooxygenase-2 inhibitor rofecoxib (25 mg every morning) and the same medications in the reverse order; enteric-coated aspirin two hours before ibuprofen (400 mg three times a day); and enteric-coated aspirin two hours before delayed-release diclofenac (75 mg twice daily) RESULTS: Serum thromboxane B(2) levels (an index of cyclooxygenase-1 activity in platelets) and platelet aggregation were maximally inhibited 24 hours after the administration of aspirin on day 6 in the subjects who took aspirin before a single daily dose of any other drug, as well as in those who took rofecoxib or acetaminophen before taking aspirin. In contrast, inhibition of serum thromboxane B(2) formation and platelet aggregation by aspirin was blocked when a single daily dose of ibuprofen was given before aspirin, as well as when multiple daily doses of ibuprofen were given. The concomitant administration of rofecoxib, acetaminophen, or diclofenac did not affect the pharmacodynamics of aspirin CONCLUSIONS: The concomitant administration of ibuprofen but not rofecoxib, acetaminophen, or diclofenac antagonizes the irreversible platelet inhibition induced by aspirin. Treatment with ibuprofen in patients with increased cardiovascular risk may limit the cardioprotective effects of aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It can also antagonize the platelet inhibition induced by low dose aspirin and lessens its cardioprotective effect (46).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A. S., Shapiro, D., Burgos‐Vargas, R., Davis, B. R., Day, R. O., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,014
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,572
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S. C., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,304
Self-citationThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,270
Patrono, C., Coller, B. S., Dalen, J. E., Gerald, G. A. F., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.39s · Cited by 961
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 931
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A. B., Barnett, J. W., Chow, J., Ramesha, C. S., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 620
Catella-Lawson, F., McAdam, B. F., Morrison, B. W., Kapoor, S. C., Kujubu, D. A., Antes, L. M., Lasseter, K. C., Quan, H., Gertz, B. J., & FitzGerald, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 596
Self-citation
Flagged first, then by citations
Research works printed but not linked: 7
- Singh G, 1999, J Rheumatol, 26, 18
- Patrignani P, 1999, J Physiol Pharmacol, 50, 661
- Pathmakanthan S, 1998, Ir Med J, 91, 58
- Patrignani P, 1994, J Pharmacol Exp Ther, 271, 1705
- Sciulli MG, Patrignani P, Seta F, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells in vitro. In: Proceedings of the 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, Florence, Italy, June 4–8, 2000:38. abstract.
- Reilly IAG, 1987, Blood, 69, 180, 10.1182/blood.V69.1.180.180 · DOI
- Catella-Lawson F, 1999, J Pharmacol Exp Ther, 289, 735
Cited by
Sorted by citations
Items 801–900 of 1,000
McKellar, G., Madhok, R., & Singh, G. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282fb03ec · Cited by 9
Celecoxib interferes to a limited extent with aspirin‐mediated inhibition of platelets aggregation
Ruzov, M., Rimon, G., Pikovsky, O., & Stepensky, D. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12801 · Cited by 9
Cox-2 inhibitors in mandibular third molar surgery
Janarthanan, K., & Adalarasan, S. (2019) · Journal of Medicine and Life · doi:10.25122/jml-2019-0007 · Cited by 9
Schwartz, J. I., Musser, B. J., Tanaka, W. K., Taggart, W. V., Mehta, A., Gottesdiener, K. M., & Greenberg, H. E. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.194 · Cited by 9
Chou, R., Helfand, M., & Peterson, K. (2006) · Cited by 9
Petreñas, L. C., & Yubero, C. G. (2010) · Farmacia Hospitalaria (English Edition) · doi:10.1016/s2173-5085(10)70062-9 · Cited by 9
Kuliczkowski, W., Witkowski, A., Watała, C. W., Filipiak, K. J., Budaj, A., Golański, J., Sitkiewicz, D., Pręgowski, J., Górski, J., Zembala, M., et al. (2008) · PubMed · Cited by 9
A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety
Szőke, K., Czompa, A., Lekli, I., Szabados-Fürjesi, P., Herczeg, M., Csávás, M., Borbás, A., Herczegh, P., & Tósaki, Á. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.02.020 · Cited by 9
Großer, T., Fries, S., & FitzGerald, G. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50793-x · Cited by 9
Self-citationShould People on Aspirin Avoid Ibuprofen?
Cheema, A. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000107892.83612.9d · Cited by 9
Aspirin resistance – does it clinically matter?
Schrör, K., Hohlfeld, T., & Weber, A.-A. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0424-5 · Cited by 9
Hochman, J. S., & Shah, N. R. (2006) · Circulation · doi:10.1161/circulationaha.106.634386 · Cited by 9
The use of anti-inflammatory analgesics in the patient with cardiovascular disease
Steinhubl, S. R. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.034 · Cited by 9
Chiappini, E., Orlandi, M., Chiarugi, A., Mauro, A. D., Insalaco, A., Milani, G. P., Vallini, M., & Vecchio, A. L. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1452226 · Cited by 8
Intercalation of manganese-mefenamic acid complex into double stranded of calf thymus DNA
Shahabadi, N., jamshidi, Z., Hadidi, S., Shiri, F., & Fatahi, N. (2019) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2019.1625379 · Cited by 8
Dannenberg, L., Metzen, D., Zako, S., Pöhl, M., Mourikis, P., Helten, C., Trojovsky, K., Naguib, D., Konsek, D., Knoop, B., et al. (2019) · Pharmacology · doi:10.1159/000503582 · Cited by 8
Reducing NSAID-induced gastrointestinal complications
(2011) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2011.02.0007 · Cited by 8
Ahmadi, N., Khoramjouy, M., Movahed, M. A., Amidi, S., Faizi, M., & Zarghi, A. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206269563231220104846 · Cited by 8
Pharmacotherapeutic agents used in temporomandibular disorders
Bal, B., Kaya, S. T., Motro, P. F. K., & Oral, K. (2014) · Oral Diseases · doi:10.1111/odi.12255 · Cited by 8
Shi, G., Zhou, Y., & Ren, F. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104358 · Cited by 8
Mariniello, D. F., Allocca, V., D’Agnano, V., Villaro, R., Lanata, L., Bagnasco, M., Aronne, L., Bianco, A., & Perrotta, F. (2022) · Molecules · doi:10.3390/molecules27248919 · Cited by 9
Wei, J., Zeng, C., Lane, N. E., Li, X., Lei, G., & Zhang, Y. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad094 · Cited by 8
Knoepp, S. M., & Laposata, M. (2005) · Pathology Patterns Reviews · doi:10.1309/014ukwnqln7cvyxx · Cited by 8
The COX 2 selective inhibitors: what the newspapers have not told you.
Simon, L. S. (2007) · PubMed · Cited by 8
Mishra, P. K. (2010) · Cited by 8
The COX-2 inhibitors: a reasoned review of the data
Simon, L. S. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.10983 · Cited by 8
Aspirin Use Prior to Coronary Artery Bypass Grafting Surgery: a Systematic Review
Elbadawi, A., Saad, M. S., & Nairooz, R. S. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0822-5 · Cited by 8
Encapsulation of Aspirin into parent and functionalized MCM-41, in vitro release as well as kinetics
Solanki, P., & Patel, A. (2019) · Journal of Porous Materials · doi:10.1007/s10934-019-00750-w · Cited by 8
Patrono, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00050-3 · Cited by 10
A Review of Antiplatelet Drugs, Coronary Artery Diseases and Cardiopulmonary Bypass
Ren, Y., Patel, K. P., & Crane, T. (2010) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/201042103 · Cited by 8
Antiplatelet Agents and Arterial Thrombosis
Billett, H. H. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2007.12.007 · Cited by 8
Antiplatelet and Anticoagulant Therapy
Sabatine, M. S., & Jang, I. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-351-4_12 · Cited by 8
Cardiac Involvement in Rheumatoid Arthritis
Goodson, N. J. (2003) · Technical report · doi:10.1016/s1571-5078(03)01009-2 · Cited by 8
Antiplatelet ‘resistance’ and ‘non‐responders’: what do these terms really mean?
Serebruany, V. L., Eisert, C., Atar, D., & Ferguson, J. J. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00663.x · Cited by 8
Antiplatelet Drug Resistance: Not Ready for Prime Time
Burns, T. L., Mooss, A. N., & Hilleman, D. E. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.11.1621 · Cited by 8
Wahl, D. G., Lecompte, T., & Bounameaux, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23160 · Cited by 8
Kwoh, C. K., Anderson, L. G., Greene, J. M., Johnson, D. A., O’Dell, J. R., Robbins, M. L., Roberts, W. N., Simms, R. W., & Yood, R. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10506 · Cited by 8
Formiga, F., Rubio‐Rivas, M., Mora‐Luján, J. M., Escudero, S. C., Martinez, R. F. M., Méndez‐Bailón, M., Campo, P. D., Pérez, A. R., García-Sánchez, F.-J., Alcalá-Pedrajas, J. N., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02870-1 · Cited by 7
Hemoptysis under Diclofenac and Antiplatelet Doses of Aspirin
Yiannakopoulou, E. C. (2010) · Pharmacology · doi:10.1159/000321728 · Cited by 7
Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels
Sakata, T., & Kario, K. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.030 · Cited by 7
Yudi Pawitan, Y., Yin, L., Setiawan, A., Auer, G., Smedby, K. E. E., & Czene, K. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.02.004 · Cited by 7
Dual antiplatelet therapy in patients with diabetes mellitus: special considerations
Capranzano, P., & Capodanno, D. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.3 · Cited by 7
Rong, R., Zhang, R.-Z., Wang, X., Dan, Y.-H., Zhao, Y.-L., & Yu, Z. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01753-9 · Cited by 7
Perioperative Schmerztherapie mit Nichtopioidanalgetika
Stamer, U. M., Erlenwein, J., Freys, S. M., Stammschulte, T., Stichtenoth, D. O., & Wirz, S. (2021) · Der Schmerz · doi:10.1007/s00482-021-00566-1 · Cited by 6
Johnson, J. C., & Weinryb, J. (2006) · PubMed Central · Cited by 7
Arzneimittelinteraktionen in der Schmerztherapie
Syhr, K. M. J., Oertel, B. G., & Geißlinger, G. (2015) · Der Schmerz · doi:10.1007/s00482-015-0017-1 · Cited by 7
Lionberger, D. R., LoSchiavo, M., & Terry, M. A. (2011) · Open Access Journal of Sports Medicine · doi:10.2147/oajsm.s17048 · Cited by 7
Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery
Börgermann, J., Kanashnik, A. M., Soßdorf, M., Gummert, J. F., & Lösche, W. (2010) · Platelets · doi:10.3109/09537104.2010.502981 · Cited by 7
Aspirin treatment failure: is this a real phenomenon? A review of the aetiology and how to treat it
Shahid, F., Chahal, C. A. A., & Akhtar, M. M. (2013) · JRSM Short Reports · doi:10.1177/2042533313475576 · Cited by 7
Bartzatt, R., Cirillo, S. L. G., Cirillo, J. D., & Donigan, L. (2003) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20020108 · Cited by 7
Mechanisms of platelet activation and modification of response to antiplatelet agents.
Tselepis, A. D., Gerotziafas, G., Andrikopoulos, G. K., Anninos, H., & Vardas, P. E. (2011) · PubMed · Cited by 7
Prime Drug Interplay in Dental Practice
Mohan, S. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/16912.7434 · Cited by 7
Nonsteroidal Anti-Infl ammatory Drugs
Lal, A., & Sharma, S. (2011) · CRC Press eBooks · doi:10.1201/b10852-14 · Cited by 7
Nonsteroidal Anti-inflammatory Drugs
Ballou, L. R., & Wang, B. W. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10054-3 · Cited by 7
Solomon, D. H., Libby, P., Yeomans, N. D., Wang, Q., Wolski, K., Nissen, S. E., & Husni, M. E. (2018) · Rheumatology · doi:10.1093/rheumatology/key105 · Cited by 7
Aspirin resistance and its implications in clinical practice.
Eikelboom, J. W., Feldman, M. L., Mehta, S. R., Michelson, A. D., Oates, J. A., & Topol, E. J. (2005) · PubMed Central · Cited by 7
Spezielle Schmerztherapie bei rheumatischen Erkrankungen
Pongratz, G. (2020) · Aktuelle Rheumatologie · doi:10.1055/a-1203-5172 · Cited by 7
Antiplatelet Effect of Ketorolac in Children After Congenital Cardiac Surgery
Kim, J. S., Kaufman, J., Patel, S. S., Manco‐Johnson, M. J., Paola, J. D., & da Cruz, E. M. (2018) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/2150135118799041 · Cited by 7
Investigating the Mechanisms of Hyporesponse to Antiplatelet Approaches
D, E. B. M., Angiolillo, D. J., Bates, E., Berger, P. B., Bhatt, D. L., Cannon, C. P., Furman, M. I., Gurbel, P. A., Michelson, A. D., Peterson, E. D., et al. (2008) · Clinical Cardiology · doi:10.1002/clc.20360 · Cited by 7
Wiviott, S. D. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.07.003 · Cited by 7
Oral antiplatelet therapy and percutaneous coronary intervention
Yan, B. P.-Y., Clark, D. J., & Ajani, A. E. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.1.3 · Cited by 7
Benefits of Optimising Drug Treatment in Home-Dwelling Elderly Patients with Coronary Artery Disease
Strandberg, T. E., Pitkälä, K. H., & Tilvis, R. S. (2003) · Drugs & Aging · doi:10.2165/00002512-200320080-00004 · Cited by 7
Current and Emerging Treatments for Mild/Moderate Acute Ambulatory Pain
Weaver, A. L. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31818be66f · Cited by 7
Inhibiteurs sélectifs de COX-2 : quelle toxicité gastro-duodénale ?
Bannwarth, B. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95284-0 · Cited by 7
Celecoxib versus a Non-Selective NSAID Plus Proton-Pump Inhibitor
Chen, J. T., Pucino, F., & Resman‐Targoff, B. H. (2006) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v20n04_05 · Cited by 7
Vallano, A., Rius, R. L., & Bosch, M. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)73440-4 · Cited by 7
Clopidogrel and Calcium-Channel Antagonists
Kleiman, N. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.011 · Cited by 7
Adverse Drug Reactions Attributed to Ibuprofen
Miwa, L. J., Maneno, M. K., & Jones, J. K. (2015) · doi:10.1002/9781118743614.ch11 · Cited by 7
Burlacu, R., Bourdin, V., Blin, P., Camaioni, F., Clairaz, B., Lantéri‐Minet, M., Laroche, F., Raineri, F., Perrot, S., Stahl, J. ‐., et al. (2024) · Therapies · doi:10.1016/j.therap.2024.10.061 · Cited by 6
Petreñas, L. C., & Yubero, C. G. (2010) · Farmacia Hospitalaria · doi:10.1016/j.farma.2009.08.002 · Cited by 6
Indications and Evidence for Dual Antiplatelet Therapy After Acute Ischemic Stroke
Ringler, J., Steck, M., Shah, S. P., & Chester, K. W. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000298 · Cited by 6
Intestinal injury in paracetamol overdose (ATOM‐8)
Perananthan, V., Shihana, F., Chiew, A. L., George, J., Dawson, A. H., & Buckley, N. A. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16450 · Cited by 8
Aspirin resistance and ischemic heart disease on Iranian experience
Sadeghi, M., Naini, A. E., Ziaie, N., Yaran, M., Golabchi, A., & Sadeghi, A. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.99345 · Cited by 6
Therapy Against Ischemic Injury
Guarini, G., Huqi, A., Capozza, P., Morrone, D., Donati, F., & Marzilli, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319250008 · Cited by 6
Deepa, R., Mohan, V., Premanand, C., RAJAN, V. S., Karkuzhali, K., Velmurugan, K., Agarwal, S., Gross, M., & Markovitz, J. H. (2006) · PubMed · Cited by 6
Drug interactions in the setting of acute coronary syndromes and dual anti-platelet therapy
Bassand, J. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul053 · Cited by 6
Testing Cardiovascular Drug Safety and Efficacy in Randomized Trials
FitzGerald, G. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.301809 · Cited by 6
Self-citationSakata, C., Suzuki, K., Morita, Y., & Kawasaki, T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.015 · Cited by 6
Li, X., Mazaleuskaya, L. L., Ballantyne, L. L., Meng, H., FitzGerald, G. A., & Funk, C. D. (2018) · The FASEB Journal · doi:10.1096/fj.201800252r · Cited by 6
Self-citationPolypharmacy and Rational Prescribing: Changing the Culture of Medicine One Patient at a Time
Yoon, S. K., Okyere, B., & Strasser, D. C. (2019) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-019-00220-z · Cited by 6
Willerson, J. T., & Armstrong, P. W. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.018 · Cited by 6
High On-Treatment Platelet Reactivity in Peripheral Endovascular Procedures
Spiliοpoulos, S., Kassimis, G., Hatzidakis, A. A., & Krokidis, M. E. (2013) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-013-0707-y · Cited by 6
Mosaad, S. M., Zaitone, S. A., Ahmed, A. A. M., Abo–Elmatty, D. M., El-Baz, A. A., & Moustafa, Y. M. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1342-y · Cited by 6
Chang, S. H., Song, Y., & Nah, S. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/3165125 · Cited by 6
Perioperative Schmerztherapie mit Nichtopioidanalgetika
Stamer, U. M., Erlenwein, J., Freys, S. M., Stammschulte, T., Stichtenoth, D. O., & Wirz, S. (2021) · Der Chirurg · doi:10.1007/s00104-021-01421-w · Cited by 8
Kaber, G., Kaiser, B., Baumgärtel-Allekotte, D., Rauch, B. H., Noßmann, S., Heim, K., Aa, W., Nagy, N., Fischer, J., & Schrör, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01392.x · Cited by 6
Reny, J., Bonvini, R. F., Bonvini, J. M., Roffi, M., & Fontana, P. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00248.x · Cited by 6
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?
Yuan, Y., & Hunt, R. H. (2003) · Inflammopharmacology · doi:10.1163/156856003322699528 · Cited by 6
ASHP Therapeutic Position Statement on the Daily Use of Aspirin for Preventing Cardiovascular Events
Saseen, J. J. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040599 · Cited by 6
Abramson, S. B., & Greenberg, J. D. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0763 · Cited by 6
Lancaster, G. I., Srinivasan, J. R., & Jain, H. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0017-7 · Cited by 6
Taking the stress out of managing gout.
Laubscher, T. A., Dumont, Z. J., Regier, L. D., & Jensen, B. (2009) · PubMed Central · Cited by 6
Labuz-Roszak, B. M., Pierzchała, K., Niewiadomska, E., Skrzypek, M., & Machowska-Majchrzak, A. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49211 · Cited by 6
Nonsteroidal Anti-inflammatory Drugs
Moilanen, E., & Vuolteenaho, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-10811-3_33 · Cited by 6
Measurement of the Antiplatelet Effects of Aspirin in Cerebrovascular Disease
McCabe, D. J. H., Harrison, P., Machin, S. J., Watt, H., & Brown, M. M. (2004) · Stroke · doi:10.1161/01.str.0000126474.25720.3e · Cited by 6
Reduction of jaw opening in giant cell arteritis
Liozon, É., Jauberteau, M., Ly, K. H., Loustaud, V., Soria, P., Vidal, E., Nir‐Paz, R., & Chajek-Shaul, T. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.3.287-a · Cited by 6
Bassand, J., Hamm, C. W., Boersma, E. H., Hasdai, D., Ohman, E. M., Wallentin, L. C., & Wijns, W. C. (2007) · Cited by 6
The dawn of neurosurgery in pre-conquest Mesoamerican territories
Zuccaro, G. N. (2017) · Child s Nervous System · doi:10.1007/s00381-017-3464-4 · Cited by 6
Milani, G. P., Nicolini, G., Cananzi, M., Spiezia, L., & Vidal, E. (2026) · Children · doi:10.3390/children13010071 · Cited by 5
Katsanopoulou, M., Zannas, Z., Ofrydopoulou, A., Maria, C., Krokidis, X., Lambropoulou, D. A., & Τσούπρας, Α. (2025) · Medicina · doi:10.3390/medicina61081413 · Cited by 6
Metadata
- Authors
- Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-20
- Volume
- 345
- Issue
- 25
- Pages
- 1809-1817
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2011327495
- Cited by
- 1,394
- References
- 44
- Citations by year
- 2026: 19 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 40 · 2018: 40 · 2017: 46 · 2016: 41 · 2015: 56 · 2014: 46 · 2013: 69 · 2012: 79
- FWCI
- 50.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 5400, HL62250, P01HL062250)
- National Center for Research Resources (M01-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- aspirin, ibuprofen, cyclooxygenase inhibitors, rofecoxib, diclofenac, paracetamol, drug interactions, platelet aggregation, thromboxane B2, antiplatelet activity, nonsteroidal anti-inflammatory drugs, arthritis treatment, cardiovascular risk, cardioprotection
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Diclofenac, Drug Interactions, Drug Therapy, Combination, Humans, Ibuprofen, Isoenzymes, Lactones, Membrane Proteins, Middle Aged, Platelet Aggregation, Platelet Aggregation Inhibitors, Prostaglandin-Endoperoxide Synthases, Sulfones, Thromboxane B2, Dinoprostone, Cyclooxygenase Inhibitors, Cross-Over Studies, Analgesics, Non-Narcotic, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
